The early symptoms of Alzheimer’s disease include decreased judgment, lack of initiative, challenges in solving problems, difficulty completing tasks, and withdrawal from social activities.

Residents at Senior Living Residences' Standish Village organized a fundraiser to benefit Haiti Relief.

I have a different picture of Alzheimer’s for you today, shared with me by Brooke Patterson, Memory Support Neighborhood (MSN) Program Director at Standish Village, a community owned and managed by Senior Living Residences.

Most days Brooke begins her day by encouraging the residents, living on the MSN, to come to her daily activity program. The day after the earthquake in Haiti, she came into the community and asked the residents to do just that. The residents all looked at her and asked, “What are we going to do?” She smiled and replied, “Something fun,” the response she offers on most days. The residents looked at her and said “Don’t you know what is going on in the world? We shouldn’t be having fun, we need to do something to help!”

More residents of Standish Village who are organizing a food and water drive to benefit haiti Relief efforts

Hearing about the tragic earthquake that occurred in Haiti, the residents were driven to action to offer compassionate assistance to those in need like many of us across the globe. Responding to the crisis, they have organized a community-wide food and water drive to donate to the Haitian Relief efforts.

The resident-directed drive was organized by individuals who are actively engaged, directed in their purpose, and proud of their compassionate efforts. Each one is living with Alzheimer’s disease.

www.nature.com/.../n1s/full/jcbfm2009170a.html

As with Alzheimer’s disease, there is no simple way to reach a diagnosis of Mild Cognitive Impairment (MCI). Individuals who notice symptoms associated with MCI, including forgetting appointments and details of recent events or conversations as well as frequently repeating conversations and information, should speak to their physician.

During the diagnostic process, one can expect to be asked a number of questions about noted changes, history of symptoms and a family health history. In addition, the physician may ask to speak with a family member or close friend, to ask about observation of symptoms.

From there, a number of tests will be conducted to eliminate other potential causes for memory loss including: a complete physical exam, blood tests, an evaluation for depression or other mental illness, brain imaging, and a neuropsychological assessment.

The process is very involved, but once completed offers a clear picture of what is causing memory changes. It is important to note that not all memory change is caused by Alzheimer’s disease. At times, memory loss may be caused by an acute condition that can be treated. Also, as researchers learn more and more about memory loss, recognition of the earliest changes in cognition will lead to the most effective treatment.

A recent study from the University of Central Florida (UCF), provides new information about the earliest stages of Alzheimer’s disease, where preventative treatment is possible.

Among scientists and many lay people, it is well known that beta-amyloid is a destructive force to nerve cells in people suffering from Alzheimer’s disease. Beta-amyloid builds up in the brain, clumping in neurons and forming damaging deposits knows as plaque. This plaque is one of the hallmarks of Alzheimer’s disease.

In the disease process, the beta-amyloid damages and eventually kills neurons, brain cells. Many research studies have focused on the damaged nerve cells in trying to understand this process towards seeking a possible prevention and treatment.

In this new study, researchers from UCF looked at smaller amounts of beta-amyloid and its effect on healthy nerve cells. The scientists found that this more moderate exposure to the beta-amyloid has an effect on the cells, preventing the normal transfer of electronic signals in the brain.

The discovery is important in that it provides evidence that changes are occurring in the brain well before there are any noted changes to memory or behavior, that is, symptoms of the disease. This information may be valuable in the quest for a treatment that works in the earliest stages of the disease, suitable for an individual with the mild cognitive impairment.

More research is needed to fully understand the role of beta-amyloid in Alzheimer’s disease as well as potential treatments.

Have you ever heard the term Mild Cognitive Impairment (MCI)?

More and more, I see this term used for the general public: to describe newsworthy findings of studies about memory and aging, in educational materials from leading organizations like the Alzheimer’s Association, and from neurologists caring for people experiencing memory loss.

MCI refers to the stage between the cognitive decline associated with normal aging and the more serious changes associated with Alzheimer’s disease, marked by progressive loss of memory and day to day functional abilities.

Researchers and scientist are particularly interested in studying people with MCI as they may be seeing Alzheimer’s disease (AD) at its earliest stage. People with MCI are an important part of research studies seeking information about biomarkers, risk factors, and prevention of AD.

Senior Living Residences, www.seniorlivingresidences, is currently implementing a number of cognitive health initiatives to help people living with the memory changes associated with MCI and the earliest stages of Alzheimer’s disease.

Visit this blog again for information on the diagnosis, treatment, and services available for people with Mild Cognitive Impairment.